{"name":"Respira Therapeutics, Inc.","slug":"respira-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"Respira Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for respiratory diseases. The company's lead product, Vardenafil Oral Tablet, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxNS2toYUlteGtydXJCZTh6V042aGVWZ2sxeDBEbXdVYXBDTzZrOEljckhEZ2ZiUEpnbEVKUDNCYWozZnNheDlIa3JMd0ZScHhJQjVvNGtQNjhLNWlfQlhIdGY3eXYxX2paa0Uydk1ibE1TMUJXZkJxTk0takF6MUNtMVpHUy0yY3FQTUVGYVBoUTRYOTNhem50VnNlNTNickd4cmdUZ1I1aGNOaWtfLXhXLURrekpBc1FYMmIyN2pIajg3cjdjY2gzZmhKZjlsVjZ3UGtSdm1xem5NNVhJTFJ6MXU5MmR3bWt5eUltc3o5QVFkY0s2UFVwSFl6VzdYd2VGbjc4V3k2RGlza2dSaTdBT2dKbFcxTUVRcG9MWndB?oc=5","date":"2025-09-25","type":"deal","source":"PR Newswire","summary":"Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital - PR Newswire","headline":"Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPQ0FjUDFSRHJjbWZjQkNUNTN2ZktxWGhVZHZHN3AzcDl3cG41aDhQRlpMaVF3VWtOOFYwWDMyN2t5dXU3U29BYzEwY24tekR6U2NGbDRMTWxSYVRxT0lJMGJxTEtGM3g5ZVV5Y3hiMXFTQUt1V3hoNW9xZVBVaEZQVzBXei1VRmJGeDR5dU5yckdCOVhu?oc=5","date":"2025-09-25","type":"deal","source":"The Pharma Letter","summary":"Gossamer Bio granted option to acquire Respira - The Pharma Letter","headline":"Gossamer Bio granted option to acquire Respira","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-07-19","type":"pipeline","source":"PR Newswire","summary":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B","headline":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Ba","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNcUNvbVMxcVVDcDdnQkU1WklDWFhjbW95V081T2wxMW4ycWtJc1MxS21DNkJBWGVFWnJoa2ZaQnRpRkh6NWo0MlJEbEtmVG9JcUZKaVZWdklPcnU4MnVxa0hyMG9aNWVvODhFRlMzVXhvc3pJazFxR21qYlhaVldrQ1g5OS1sb2g5VGtZTElpOXQ2Y2plUXhReTYtNEdhdVVnMzl3TXdQN0c1QmhQS19ST0pOcU85eG5q?oc=5","date":"2022-09-30","type":"pipeline","source":"The Business Journals","summary":"Here's how a name dispute became an opportunity for reinvention for this Inno Madness-winning founder - The Business Journals","headline":"Here's how a name dispute became an opportunity for reinvention for this Inno Madness-winning founder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxQTERCd2Y3Sk8zSFFMR1hQNTVGWFRQQl9JRHJSOVlNMjJOYzlRY0pzQVcyOVZPQWhkcEVlWnhudEp6dXNma0pkdy1yRGtYZ0w3eExzYVgyWjVwQmx0VGNEeDcxX2JWS1gwWFBWZzRoNmRRLV8yejdaZ0VFQmxnajJmUkludU5veHU3b25pTFlPWm9rV0tIZFJaR2NEVXh5dUlUNHo1bDVGN0oySjlLVmhoaG5YYzRWcFRRRWdvMUZFMlI1RXJQYkNrQTZTX1ZTd2ZXWDdLaEZVZVN1YWpVRUZYUEVoVkF0M1hFa3dMdjVCVm9YOXdweGdsbkdPNXEtdU1mUzVzVGd6aUstRWRBdU96aWI5SmxoM1hKSlRJYWxTUnBleUFNY1E?oc=5","date":"2022-04-05","type":"trial","source":"PR Newswire","summary":"Respira Therapeutics Announces First Patient Dosed in Phase 2b VIPAH-PRN 2b Trial of RT234 in Patients with Pulmonary Arterial Hypertension (PAH) - PR Newswire","headline":"Respira Therapeutics Announces First Patient Dosed in Phase 2b VIPAH-PRN 2b Trial of RT234 in Patients with Pulmonary Ar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPYUViYXNFdU5MZ2JjM2x2ckczQXJzbHYzamNzNFpQSEhlTjlEd1hPVWpEZWpWNFczTW9KWFFQTkxsY2tGN1dTYjlxeG5JOEFXVW9IMUExU1hYTlpTY2RpZXRWY0pleDdDRnF4WS1zLWhILVFFVnFYRlozR3paMDBOSU82YzFjNUxldWMwUmdWTFlZZml0OGtCV2NDbXpWdDFzVXloZy10cm9qVnBPWm5GMmM2clQwRmtjbG1Qa2VhelBTcE5zS2ZodW0tUFRrNjgzVUlQdEgzZEFvV1A3cDdkSF9YY3FsdHZvYm1VUy1n?oc=5","date":"2017-04-12","type":"deal","source":"PR Newswire","summary":"Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension - PR Newswire","headline":"Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}